• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sharon Sanders Interviews William Schaffner, M.D. Monday March 15, 2009 4PM EST

sharon sanders

sharon sanders

Editor-in-Chief & President
Dr. William Schaffner resume:

Liasion Member of the USA CDC Advisory Committee on Immunization Practices (ACIP) for the National Foundation for Infectious Diseases (NFID)

[FONT=&quot]
[/FONT]
[FONT=&quot]Academic Rank:[/FONT][FONT=&quot] Professor of Preventive Medicine and Medicine [/FONT]
[FONT=&quot]Title:[/FONT][FONT=&quot] Chairman, Department of Preventive Medicine[/FONT]

[FONT=&quot]Joined Vanderbilt[/FONT][FONT=&quot]:1969
[/FONT]

[FONT=&quot]Education & Training[/FONT]
[FONT=&quot]Undergraduate [/FONT][FONT=&quot]Yale, 1957[/FONT]
[FONT=&quot]Medical School[/FONT][FONT=&quot] Cornell University Medical College, 1962 [/FONT]
[FONT=&quot]Residency[/FONT][FONT=&quot] Vanderbilt University, 1964 [/FONT]
[FONT=&quot]Chief Residency[/FONT][FONT=&quot] Vanderbilt University, 1969[/FONT]
[FONT=&quot]Fellowship [/FONT]

[FONT=&quot]Professional Association Leadership Roles[/FONT]
<!--[if !supportLists]-->[FONT=&quot]1.[/FONT]<!--[endif]-->[FONT=&quot]SHEA, President 1983 [/FONT]
<!--[if !supportLists]-->[FONT=&quot]2.[/FONT]<!--[endif]-->[FONT=&quot]IDSA, Council 2000-2003 [/FONT]
<!--[if !supportLists]-->[FONT=&quot]3.[/FONT]<!--[endif]-->[FONT=&quot]ASM, Division of Nosocomial Infections, Chair 1983-1984 [/FONT]

[FONT=&quot]Editorial board membership[/FONT]
<!--[if !supportLists]-->[FONT=&quot]1.[/FONT]<!--[endif]-->[FONT=&quot]Clinical Research, 1974-1984 [/FONT]
<!--[if !supportLists]-->[FONT=&quot]2.[/FONT]<!--[endif]-->[FONT=&quot]Infection, 1985-present [/FONT]
<!--[if !supportLists]-->[FONT=&quot]3.[/FONT]<!--[endif]-->[FONT=&quot]American Journal of Epidemiology, 1987-1997 [/FONT]
<!--[if !supportLists]-->[FONT=&quot]4.[/FONT]<!--[endif]-->[FONT=&quot]European Journal of Clinical Microbiology and Infectious Diseases, 1993-present [/FONT]
<!--[if !supportLists]-->[FONT=&quot]5.[/FONT]<!--[endif]-->[FONT=&quot]Infection Control and Hospital Epidemiology Senior Associate Editor, 1981-present [/FONT]
<!--[if !supportLists]-->[FONT=&quot]6.[/FONT]<!--[endif]-->[FONT=&quot]Journal of Infectious Diseases Associate Editor, 2003-present [/FONT]

[FONT=&quot]Honors/Awards[/FONT]
<!--[if !supportLists]-->[FONT=&quot]1.[/FONT]<!--[endif]-->[FONT=&quot]Ford Foundation Scholar, Yale University (1953-1957)[/FONT]
<!--[if !supportLists]-->[FONT=&quot]2.[/FONT]<!--[endif]-->[FONT=&quot]Fulbright Scholar, Albert-Ludwigs University, Freiburg, Germany (1957-1958) [/FONT]
<!--[if !supportLists]-->[FONT=&quot]3.[/FONT]<!--[endif]-->[FONT=&quot]Student Fellow, Inter-American Program in Tropical Medicine, Louisiana State University, Guatemala (1962) [/FONT]
<!--[if !supportLists]-->[FONT=&quot]4.[/FONT]<!--[endif]-->[FONT=&quot]Philip S. Brachman Award: Distinguished Friend of the Epidemic Intelligence Service, Centers for Disease Control (1985)
The Shovel Award: "In recognition of teaching excellence in both word and gesture", Vanderbilt University School of Medicine, Class of 1987 [/FONT]
<!--[if !supportLists]-->[FONT=&quot]5.[/FONT]<!--[endif]-->[FONT=&quot]Alpha Omega Alpha, elected as a faculty member (1991) [/FONT]
<!--[if !supportLists]-->[FONT=&quot]6.[/FONT]<!--[endif]-->[FONT=&quot]Society of Healthcare Epidemiology (SHEA) Lecturer Award: "In recognition of extraordinary career contributions to infection control and healthcare epidemiology." (1996) [/FONT]
<!--[if !supportLists]-->[FONT=&quot]7.[/FONT]<!--[endif]-->[FONT=&quot]The William Schaffner Teaching Award in Infectious Diseases, Established by the Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine (1999) [/FONT]
<!--[if !supportLists]-->[FONT=&quot]8.[/FONT]<!--[endif]-->[FONT=&quot]Master, American College of Physicians, Elected by Board of Regents (2004) [/FONT]
<!--[if !supportLists]-->[FONT=&quot]9.[/FONT]<!--[endif]-->[FONT=&quot]William J. Darby Award: "For translation research that has changed the practice of medicine world wide", Vanderbilt University School of Medicine (2005) [/FONT]
<!--[if !supportLists]-->[FONT=&quot]10.[/FONT]<!--[endif]-->[FONT=&quot]CDC Honor Award, Asian Avian Influenza Response Team (co-awardee) "For adding substantially to the body of scientific and public health knowledge regarding avian influenza", National Center for Infectious Diseases, CDC (2005) [/FONT]


http://medicine.mc.vanderbilt.edu/Templates/TemplateDivision.aspx?qs=cElEPTcwMg==
 
Re: Sharon Sanders Interviews William Schaffner, M.D. Monday March 15, 2009 4PM EST

He has given me 30 minutes. Maybe he will stay longer...

I have so many questions:

1) Are there any measurements regarding how effective the current A/H1N1 vaccine is?

2) When will the results from the Abt study of the vaccine's effectiveness be finalized and published?

3) Just what is the deal with "low reactors"? How many are there? Does it make a difference if the passage is through animal parts, eggs, humans?

4) What are the options for the Northern Hemisphere A/H1N1 vaccine component? When will the decision be made regarding which strain will be included?

5) What adverse reactions to the vaccine have been documented and is this in the threshold of what was expected?

6) What does he see as the current status of A/H1N1 infections in the U.S. now? What about the near future? How bad is the 3rd wave?

7) What is his involvement in statins research and what is the latest?


please add more questions........
 
Re: Sharon Sanders Interviews William Schaffner, M.D. Monday March 15, 2009 4PM EST

[FONT=Geneva, Verdana, Helvetica, Arial]1. Questions: Do we have one more gene reassortment before we have a supervirus? What does Dr. Hutt mean by “one reassortment already taken place”? Reassortment with....what strain of seasonal flu? Is Dr. Hutt’s opinion that of your colleagues? If yes, what in your opinion, is the percentage of this occurring?
Dr. Huitt [department of medicine at the University of Colorado, who is also an infectious disease specialist at National Jewish Health, both in Denver. ]
“We’re treading uncharted territory right now, but the thing we’re all concerned about is whether or not we’ll have a third wave. The 1918 Spanish flu H1N1 pandemic had three waves. The second was the worst, and the third was almost as bad. So we’re just waiting to see what happens,”

Seasonal influenza A isn’t being seen on a significant scale anywhere in the world right now. However, an upsurge in seasonal influenza B is underway in China.

“Fortunately, it’s a strain included in our seasonal influenza vaccine, so I think our population should be fairly well covered if that virus starts appearing in North America,”

“All it takes is two gene reassortments. One has already taken place. So we’re waiting for the other shoe to drop, and if that occurs, then you’ve got a supervirus that’s quite lethal. ... and easily transmissible from human to human,” the physician said.
http://www.flutrackers.com/forum/showpost.php?p=342643&postcount=67

2. Question: In your gesstimate, what is the percentage of this happening?
"With the new pandemic H1N1 virus, people sort of forgot about H5N1 avian influenza. But the reality is that H5N1 avian virus is still out there," Kawaoka says. "Our data suggests that it is possible there may be reassortment between H5 and pandemic H1N1 that can create a more pathogenic H5N1."
http://www.flutrackers.com/forum/showpost.php?p=343129&postcount=73

3. Question: Is there a increased concern in Asia (China) of a mutation of H3N2? And If so, is the concern for H1N1A?
Yesterday, the National People's Congress, Chinese Academy of Engineering academician Zhong Nanshan, told reporters sounded "alarm bells": influenza in southern China is the high season of February to 6 months, there are other mutations found in H3N2 influenza viruses are most worried about mixing the virus to generate new variants.
http://www.flutrackers.com/forum/showpost.php?p=345179&postcount=74

4. Question: Is there a concern that there is a variation of H5N1 that will allow it to appear in the hot dry seasons? (Sharon, this is bringing me back to Vibrants comments about about H1N1A liking it in the hot dry season.....Could the "reassortment that Dr. Hutt was talking about have been with H1N1A????? - Is this why China and Vietnam are now talking about H5N1 being active into their Summer months?)
Vietnam:
March 3, 2010
excerpt
"Previous years, avian influenza appears in winter, cold weather. Also this year, avian influenza appears to prolonged hot and dry season. This suggests that influenza A/H5N1 virus strain variations, complicated development. Concern that avian influenza outbreaks occur in the former."
http://www.flutrackers.com/forum/showpost.php?p=345189&postcount=75

These are some excerpts that I copied out, because I thought they were very good questions....
[/FONT][FONT=Geneva, Verdana, Helvetica, Arial]Originally Posted by Laidback Al View Post
And what if, going in to the future, the world no longer has just "seasonal flu" but multiple flu strains that bombard us year around turning into a annual 12 month battle with influenza?

Vibrant62 respnds to Laidback Al’s comment:
I guess if we see a resurgence, of H3N2, and pandemic H1N1 does not develop any evolutionary advantage through adaptation to colder climates, this is very possible - with each 'family' of influenza's speiclaised to winter or spring/ autumn. However for this to happen, H2N2 would have to adapt to compete on equal terms or pandemic H1N1 would have to become less easy to transmit/ have fewer susceptible hosts.
http://www.flutrackers.com/forum/showpost.php?p=344927&postcount=391[/FONT] <!--EndFragment-->

<!--EndFragment-->
 
Re: Sharon Sanders Interviews William Schaffner, M.D. Monday March 15, 2009 4PM EST

<TABLE style="WIDTH: 911px; HEIGHT: 789px" width=911 border=0><TBODY><TR><TD>


​
</TD><TD></TD></TR><TR><TD width="29%"></TD><TD width="43%">
schaffner.jpg



​
</TD><TD width="28%"></TD></TR><TR><TD colSpan=3>WILLIAM SCHAFFNER, MD

Professor and Chairman, Department of Preventive Medicine
Professor of Medicine, Division of Infectious Diseases
Vanderbilt University School of Medicine​

<HR>William Schaffner, MD, is professor and chairman of the Department of Preventive Medicine and professor of Medicine in the Division of Infectious Diseases at Vanderbilt University School of Medicine in Nashville, Tennessee. He has served as Hospital Epidemiologist at Vanderbilt University Hospital for nearly 30 years and is an active member of 20 professional societies.

Dr. Schaffner?s work has focused on all aspects of infectious diseases, including epidemiology, infection control and immunizations. In 1996, he was awarded the Society of Healthcare Epidemiology Lecturer Award ?in recognition of extraordinary career contributions to infection control and healthcare epidemiology.?

Dr. Schaffner is a member of numerous professional societies. He is also a consultant in public health policy and communicable disease control for many national and local institutions, such as the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), the Tennessee Department of Health, the American Hospital Association and the American College of Physicians. He also serves on the board of directors for the National Foundation for Infectious Diseases (NFID).​

Dr. Schaffner is active in the field of infectious disease research and has authored or co-authored more than 230 published studies, reviews and book chapters on infectious diseases. He currently serves on the editorial board of a number of scientific journals including Hospital Infection Control, European Journal of Clinical Microbiology and Patient Care.​

Dr. Schaffner received his medical degree from Cornell University in Ithaca, New York. He was also a Fulbright Scholar (Albert Ludwigs University, Freiburg, Germany) and received his undergraduate degree from Yale University in New Haven, Connecticut.​


​
</TD></TR></TBODY></TABLE>
http://images.google.com/imgres?img...l=en&sa=X&rlz=1T4SUNA_enUS309US309&tbs=isch:1
 
Re: Sharon Sanders Interviews William Schaffner, M.D. Monday March 15, 2009 4PM EST

I think commonground has covered for me what is a primary concern with the first question.

IF you have been following the information from egypt they also expect h1n1 will be a long term issue and year round! hot, cold, wet and dry just like h5n1!
 
You must log in or register to reply here.
Back
Top